Skin Neoplasms

Displaying 1 - 42 of 42CSV
Conway, K., Edmiston, S. N., Vondras, A., Reiner, A., Corcoran, D. L., Shen, R., Parrish, E. A., Hao, H., Lin, L., Kenney, J. M., Ilelaboye, G., Kostrzewa, C. E., Kuan, P. F., Busam, K. J., Lezcano, C., Lee, T. K., Hernando, E., Googe, P. B., Ollila, D. W., … Rainka, M. (2024). DNA Methylation Classes of Stage II and III Primary Melanomas and Their Clinical and Prognostic Significance. JCO Precision Oncology, 8. https://doi.org/10.1200/po-24-00375
Publication Date
Queen, D., Trager, M. H., Fan, W., Gordon, E. R., & Samie, F. H. (2024). Assessing outcomes of topical 5-fluorouracil as primary and adjuvant therapy for squamous cell carcinoma in-situ. Archives of Dermatological Research, 316(6). https://doi.org/10.1007/s00403-024-02906-4
Publication Date
Wu, L. W., Tao, J. J., McDonnell, D., & Izar, B. (2024). Pseudoprogression in a patient with metastatic melanoma treated with PD-1 and LAG-3 inhibition. Melanoma Research, 34(4), 382–385. https://doi.org/10.1097/cmr.0000000000000974
Publication Date
Vadivel, C. K., Willerslev-Olsen, A., Namini, M. R. J., Zeng, Z., Yan, L., Danielsen, M., Gluud, M., Pallesen, E. M. H., Wojewoda, K., Osmancevic, A., Hedebo, S., Chang, Y.-T., Lindahl, L. M., Koralov, S. B., Geskin, L. J., Bates, S. E., Iversen, L., Litman, T., Bech, R., … Buus, T. B. (2024). Staphylococcus aureus induces drug resistance in cancer T cells in Sézary syndrome. Blood, 143(15), 1496–1512. https://doi.org/10.1182/blood.2023021671
Publication Date
Chen, C., Fahmy, L. M., Schreidah, C. M., Magro, C. M., & Geskin, L. J. (2024). Febrile Ulceronecrotic Mucha-Habermann Disease Associated With Hemophagocytic Lymphohistiocytosis: A Case Report and Review of the Literature. The American Journal of Dermatopathology, 46(4), 238–242. https://doi.org/10.1097/dad.0000000000002619
Publication Date
Kassotis, A. S., Grimes, J., Samie, F. H., Lewin, J. M., Levenson, J. A., & Glass, L. R. D. (2023). Risk factors for developing depressive symptoms in the immediate postoperative period after Mohs micrographic surgery. Orbit, 43(1), 22–27. https://doi.org/10.1080/01676830.2023.2179639
Publication Date
Nadir, U., Yi, M. D., Koza, E., Shi, V. J., Dave, L., Hisham, F. I., Maisel-Campbell, A., Lin, K. A., Ibrahim, S. A., Kang, B. Y., Anvery, N., Dirr, M. A., Christensen, R. E., Riley, J. M., Kundu, R. V., Aylward, J. L., Bari, O., Bhatti, H., Bolotin, D., … Alam, M. (2024). Outcomes of cutaneous surgery for nonmelanoma skin cancer in patients with different Fitzpatrick skin types: A nationwide, multicenter, prospective study. Journal of the American Academy of Dermatology, 90(6), 1243–1245. https://doi.org/10.1016/j.jaad.2023.11.069
Publication Date
Shih, B. B., Ma, C., Cortes, J. R., Reglero, C., Miller, H., Quinn, S. A., Albero, R., Laurent, A. P., Mackey, A., Ferrando, A. A., Geskin, L., & Palomero, T. (2024). Romidepsin and Afatinib Abrogate Jak–Signal Transducer and Activator of Transcription Signaling and Elicit Synergistic Antitumor Effects in Cutaneous T-Cell Lymphoma. Journal of Investigative Dermatology, 144(7), 1579-1589.e8. https://doi.org/10.1016/j.jid.2023.12.010
Publication Date
Gordon, E. R., Kwinta, B. D., Schreidah, C. M., Fahmy, L. M., Adeuyan, O., Queen, D., Trager, M. H., Magro, C. M., & Geskin, L. J. (2023). Cutaneous lymphoproliferative disorders after COVID-19 vaccination: clinical presentation, histopathology, and outcomes. Leukemia & Lymphoma, 65(1), 48–54. https://doi.org/10.1080/10428194.2023.2270766
Publication Date
Ko, B., Tao, K., Brennan, L., Rakhade, S., Chan, C. X., Moone, J.-Y., Zhu, R., Sher, A., Wang, S., Bracero, Y., Fullerton, B., McLellan, B., Geskin, L. J., & Saenger, Y. M. (2024). Evaluating the efficacy of combination and single-agent immunotherapies in real-world patterns of disease progression and survival of metastatic melanoma patients. Melanoma Research, 34(2), 134–141. https://doi.org/10.1097/cmr.0000000000000945
Publication Date
Trager, M. H., Queen, D., Denson, E., Fan, W., Youssef, S., & Samie, F. H. (2023). Pre-operative drawings of anticipated closures as a visual tool to align patient and physician expectations for Mohs and reconstructive surgery. Archives of Dermatological Research, 316(1). https://doi.org/10.1007/s00403-023-02774-4
Publication Date
GORDON, E. R., ADEUYAN, O., SCHREIDAH, C. M., CHEN, C., TRAGER, M. H., LAPOLLA, B. A., FAHMY, L. M., WENG, C., & GESKIN, L. J. (2023). Clusters, crop dusters, and myth busters: a scoping review of environmental exposures and cutaneous T-cell lymphoma. Italian Journal of Dermatology and Venereology, 158(6). https://doi.org/10.23736/s2784-8671.23.07729-0
Publication Date
Gaydosik, A. M., Stonesifer, C. J., Tabib, T., Lafyatis, R., Geskin, L. J., & Fuschiotti, P. (2023). The mycosis fungoides cutaneous microenvironment shapes dysfunctional cell trafficking, antitumor immunity, matrix interactions, and angiogenesis. JCI Insight, 8(19). https://doi.org/10.1172/jci.insight.170015
Publication Date
Pavlick, A. C., Ariyan, C. E., Buchbinder, E. I., Davar, D., Gibney, G. T., Hamid, O., Hieken, T. J., Izar, B., Johnson, D. B., Kulkarni, R. P., Luke, J. J., Mitchell, T. C., Mooradian, M. J., Rubin, K. M., Salama, A. K., Shirai, K., Taube, J. M., Tawbi, H. A., Tolley, J. K., … Sullivan, R. J. (2023). Society for Immunotherapy of Cancer (SITC) clinical practice guideline on immunotherapy for the treatment of melanoma, version 3.0. Journal for ImmunoTherapy of Cancer, 11(10), e006947. https://doi.org/10.1136/jitc-2023-006947
Publication Date
Geskin, L. J., Angello, J. T., Bagot, M., Guenova, E., Nikbakht, N., Querfeld, C., & Scarisbrick, J. J. (2024). Evaluating Response Trends of Chlormethine/Mechlorethamine Gel in Patients With Stage I-IIA Mycosis Fungoides: Analysis of Individual Patient Data From a Randomized Controlled Phase II Study to Facilitate Optimal Treatment Experiences. Clinical Lymphoma Myeloma and Leukemia, 24(1), 40–47. https://doi.org/10.1016/j.clml.2023.08.020
Publication Date
Morales, L. C., Santos, L., Fenlon, E., Remotti, F., Middlesworth, W., & Jaramillo, D. (2023). Fibrous hamartoma of infancy: imaging findings. Pediatric Radiology, 53(10), 2048–2053. https://doi.org/10.1007/s00247-023-05701-x
Publication Date
Rust, D. J., Kwinta, B. D., Geskin, L. J., Samie, F. H., Remotti, F., & Yoon, S. S. (2023). Surgical management of dermatofibrosarcoma protuberans. Journal of Surgical Oncology, 128(1), 87–96. Portico. https://doi.org/10.1002/jso.27258
Publication Date
Widaatalla, Y., Wolswijk, T., Adan, F., Hillen, L. M., Woodruff, H. C., Halilaj, I., Ibrahim, A., Lambin, P., & Mosterd, K. (2023). The application of artificial intelligence in the detection of basal cell carcinoma: A systematic review. Journal of the European Academy of Dermatology and Venereology, 37(6), 1160–1167. Portico. https://doi.org/10.1111/jdv.18963
Publication Date
Geller, A. C., Coroiu, A., Keske, R. R., Haneuse, S., Davine, J. A., Emmons, K. M., Daniel, C. L., Gibson, T. M., McDonald, A. J., Robison, L. L., Mertens, A. C., Elkin, E. B., Marghoob, A., & Armstrong, G. T. (2023). Advancing Survivors Knowledge (ASK Study) of Skin Cancer Surveillance After Childhood Cancer: A Randomized Controlled Trial in the Childhood Cancer Survivor Study. Journal of Clinical Oncology, 41(12), 2269–2280. https://doi.org/10.1200/jco.22.00408
Publication Date
Quaglino, P., Scarisbrick, J., Roccuzzo, G., Abeldano, A., Battistella, M., McCormack, C., Cowan, R., Cozzio, A., Cury‐Martins, J., Enz, P., Geskin, L., Guenova, E., Kim, Y. H., Knobler, R., Litvinov, I. V., Miyagaki, T., Molgo, M., Nicolay, J., Papadavid, E., … Hodak, E. (2023). Identifying unmet needs and challenges in the definition of a plaque in mycosis fungoides: An EORTC‐CLTG/ISCL survey. Journal of the European Academy of Dermatology and Venereology, 37(4), 680–688. Portico. https://doi.org/10.1111/jdv.18852
Publication Date
Geskin, L. J., Kwinta, B. D., Garcia-Saleem, T. J., Akilov, O. E., Enz, P. A., Guenova, E., Ortiz-Romero, P. L., Papadavid, E., Quaglino, P., Rozati, S., Stonesifer, C. J., Burns, A., Stringer, W. S., Tarin, E., & Scarisbrick, J. J. (2023). International Society for Cutaneous Lymphomas Pandemic Section (ICLYPS) analysis of cutaneous T-cell lymphoma outcomes during the COVID-19 pandemic: A retrospective cohort study. Journal of the American Academy of Dermatology, 88(4), 935–937. https://doi.org/10.1016/j.jaad.2022.11.016
Publication Date
Shim, J., Park, J., Jung, Y. J., Jang, K., Kwon, E. J., Lee, J. H., & Lee, D. (2023). Molecular characterization of onychomatricoma: Spatial profiling reveals the role of onychofibroblasts in its pathogenesis. Experimental Dermatology, 32(4), 491–501. Portico. https://doi.org/10.1111/exd.14736
Publication Date
Welch, D., Kleiman, N. J., Arden, P. C., Kuryla, C. L., Buonanno, M., Ponnaiya, B., Wu, X., & Brenner, D. J. (2022). No Evidence of Induced Skin Cancer or Other Skin Abnormalities after Long‐Term (66 week) Chronic Exposure to 222‐nm Far‐UVC Radiation. Photochemistry and Photobiology, 99(1), 168–175. Portico. https://doi.org/10.1111/php.13656
Publication Date
Hodak, E., Geskin, L., Guenova, E., Ortiz-Romero, P. L., Willemze, R., Zheng, J., Cowan, R., Foss, F., Mangas, C., & Querfeld, C. (2022). Real-Life Barriers to Diagnosis of Early Mycosis Fungoides: An International Expert Panel Discussion . American Journal of Clinical Dermatology, 24(1), 5–14. https://doi.org/10.1007/s40257-022-00732-w
Publication Date
Wu, H.-C., Kehm, R., Santella, R. M., Brenner, D. J., & Terry, M. B. (2022). DNA repair phenotype and cancer risk: a systematic review and meta-analysis of 55 case–control studies. Scientific Reports, 12(1). https://doi.org/10.1038/s41598-022-07256-7
Publication Date
Wei, A. Z., Maniar, A. B., & Carvajal, R. D. (2022). New targeted and epigenetic therapeutic strategies for the treatment of uveal melanoma. Cancer Gene Therapy, 29(12), 1819–1826. https://doi.org/10.1038/s41417-022-00443-8
Publication Date
Luo, L., Shen, R., Arora, A., Orlow, I., Busam, K. J., Lezcano, C., Lee, T. K., Hernando, E., Gorlov, I., Amos, C., Ernstoff, M. S., Seshan, V. E., Cust, A. E., Wilmott, J., Scolyer, R. A., Mann, G., Nagore, E., Funchain, P., … Ko, J. (2022). Landscape of mutations in early stage primary cutaneous melanoma: An InterMEL study. Pigment Cell & Melanoma Research, 35(6), 605–612. Portico. https://doi.org/10.1111/pcmr.13058
Publication Date
Kampaktsis, P. N., Doulamis, I. P., Asleh, R., Makri, E., Kalamaras, I., Papastergiopoulos, C., Emfietzoglou, M., Drosou, A., Van den Eynde, J., Alnsasra, H., Duque, E. R., & Briasoulis, A. (2022). Characteristics, Predictors, and Outcomes of Early mTOR Inhibitor Use After Heart Transplantation: Insights From the UNOS Database. Journal of the American Heart Association, 11(17). https://doi.org/10.1161/jaha.122.025507
Publication Date
Kim, E. J., Mangold, A. R., DeSimone, J. A., Wong, H. K., Seminario-Vidal, L., Guitart, J., Appel, J., Geskin, L., Lain, E., Korman, N. J., Zeitouni, N., Nikbakht, N., Dawes, K., Akilov, O., Carter, J., Shinohara, M., Kuzel, T. M., Piette, W., Bhatia, N., … Poligone, B. (2022). Efficacy and Safety of Topical Hypericin Photodynamic Therapy for Early-Stage Cutaneous T-Cell Lymphoma (Mycosis Fungoides). JAMA Dermatology, 158(9), 1031. https://doi.org/10.1001/jamadermatol.2022.2749
Publication Date
Bose, S., Lee, T., Choi, S., Fazlollahi, L., Rasiej, M. J., Schwartz, G. K., & Ingham, M. (2022). CDK4/6 Inhibition With Anti–PD-1 Checkpoint Blockade Induces Major Response in Aggressive Classic Kaposi Sarcoma After Previous Progression on Anti-PD–1 Alone. JCO Precision Oncology, 6. https://doi.org/10.1200/po.21.00550
Publication Date
Desai, A. D., Behbahani, S., & Samie, F. H. (2022). Predictors of time to definitive surgery and survival in Merkel cell carcinoma: analysis of the US National Cancer Database. Clinical and Experimental Dermatology, 47(7), 1275–1282. Portico. https://doi.org/10.1111/ced.15133
Publication Date
Maisel-Campbell, A., Lin, K. A., Ibrahim, S. A., Kang, B. Y., Anvery, N., Dirr, M. A., Christensen, R. E., Aylward, J. L., Bari, O., Bhatti, H., Bolotin, D., Cherpelis, B. S., Cohen, J. L., Condon, S., Farhang, S., Firoz, B., Garrett, A. B., Geronemus, R. G., Golda, N. J., … Schaeffer, M. R. (2022). Nonmelanoma Skin Cancer in Patients Older Than Age 85 Years Presenting for Mohs Surgery. JAMA Dermatology, 158(7), 770. https://doi.org/10.1001/jamadermatol.2022.1733
Publication Date
Gaydosik, A. M., Stonesifer, C. J., Khaleel, A. E., Geskin, L. J., & Fuschiotti, P. (2022). Single-Cell RNA Sequencing Unveils the Clonal and Transcriptional Landscape of Cutaneous T-Cell Lymphomas. Clinical Cancer Research, 28(12), 2610–2622. https://doi.org/10.1158/1078-0432.ccr-21-4437
Publication Date
Dieng, M., Lord, S. J., Turner, R. M., Nieweg, O. E., Menzies, A. M., Saw, R. P. M., Einstein, A. J., Emmett, L., Thompson, J. F., Lo, S. N., & Morton, R. L. (2022). The Impact of Surveillance Imaging Frequency on the Detection of Distant Disease for Patients with Resected Stage III Melanoma. Annals of Surgical Oncology, 29(5), 2871–2881. https://doi.org/10.1245/s10434-021-11231-3
Publication Date
Ambrosini, G., Rai, A. J., Carvajal, R. D., & Schwartz, G. K. (2022). Uveal Melanoma Exosomes Induce a Prometastatic Microenvironment through Macrophage Migration Inhibitory Factor. Molecular Cancer Research, 20(4), 661–669. https://doi.org/10.1158/1541-7786.mcr-21-0526
Publication Date
Niu, Z., Riley, M., Stapleton, J., Ochsner, M., Hernandez, G., Kimmel, L., Giovenco, D., Hudson, S., O’Malley, D., Lozada, C., Pabellón, M., Heckman, C., & Coups, E. (2022). Sunburns and Sun Protection Behaviors among Male Hispanic Outdoor Day Laborers. International Journal of Environmental Research and Public Health, 19(5), 2524. https://doi.org/10.3390/ijerph19052524
Publication Date
Scollan, M. E., Yamashiro, D. J., Niedt, G. W., & Garzon, M. C. (2022). Novel CD63‐PRKCB fusion in a case of pigmented epithelioid melanocytoma. Pediatric Dermatology, 39(2), 322–323. Portico. https://doi.org/10.1111/pde.14915
Publication Date